NCT06100159

Brief Summary

The goal of this clinical, randomized trial is to compare the sleeping patterns and quality of life of children with chronic otitis media with effusion (OME) with or without tympanic tubes insertion. The main questions it aims to answer are:

  • Does tympanic tube insertion have an effect on sleep quality in children with chronic OME?
  • Does tympanic tube insertion improve the quality of life for the children with chronic OME and their caregivers? Participants will have their movements during sleep and number of awakenings measured by an accelerometer placed on their wrist for 7 nights before and after tympanic tube insertion. Their caregivers will answer questionnaires regarding quality of life on behalf of the child. Researchers will compare with a control group of children who also is diagnosed with chronic OME. They will also have their sleep monitored for 7 nights and their caregivers will complete quality of life questionnaires, but the will not receive a tympanic tube. However the control group will be reassessed a month after baseline, and if they still qualify for tympanic tube insertion they will undergo the same routine as the intervention group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2017

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

February 17, 2017

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2022

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

October 25, 2023

Completed
Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

5.4 years

First QC Date

February 17, 2017

Last Update Submit

January 14, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in sleep quality

    Sleep length and quality. An accelerometer is fitted on the participants and measures movement in 3 axis. The movement counts from the acclerometer will be processed by Sadeh's algorithm giving assessed minutes of total sleep, awakenings and sleep quality. The outcome will be assessed by a blinded investigator.

    For the intervention group: 7 nights before and 7 nights after intervention. For the control group: 7 nights at time of inclusion.

  • Change in Quality of Life

    Quality of life quantified by the validated questionnaire OM-6. 7-point Likert scale where 1 is no problem and 7 is extreme problem. The global NRS scales were 10 point scales with o = worst possible QoL and 10 = best possible QoL

    At inclusion and up to 2 months follow up

Secondary Outcomes (1)

  • Use of pain reliever

    For the intervention group: 7 nights before and 7 nights after intervention. For the control group: 7 nights at time of inclusion.

Study Arms (2)

Tympanostomy tube

EXPERIMENTAL

Insertion of tympanostomy tubes after 3 months observation for chronic otitis media with effusion (OME) according to the National guidelines in Denmark. Sleep measurements with accelerometer 7 nights before and 7 nights after intervention. Caregivers report use of paracetamol during nights with sleep measurements.

Device: Tympanostomy tube insertion

Control

NO INTERVENTION

No tympanostomy tube treatment up to 1 month after enrollment in control group. Sleep measurements with accelerometer 7 nights at time of inclusion. Caregivers report use of paracetamol during nights with sleep measurements. After 1 month tympanic tube insertion is allowed if still chronic OME. If tympanostomy tubes are needed the children will undergo same evaluation as the intervention group.

Interventions

Ventilation tube insertion in the tympanic membrane

Also known as: ventilation tube, grommet
Tympanostomy tube

Eligibility Criteria

Age1 Year - 4 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 1-4 years with chronic otitis media with effusion and subjective hearing loss
  • \. time ventilation tube insertion
  • ASA group 1 and 2

You may not qualify if:

  • Recurrent AOM
  • Concomitant adenoidectomy or adenotonsillectomy
  • Lip-gum-cleft anomalies or other craniofacial malformations
  • Downs syndrome
  • Existing sleep apnea
  • Asthmatic bronchitis or other chronic lung diseases like CF or other sleep disorders
  • ASA \> 2
  • Children with hyperkinetic syndrome
  • Present breastfeeding during night
  • Not fluent in Danish language
  • Other systemic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ørelægerne Fredericia

Fredericia, 7000, Denmark

Location

Peter Tingsgaard

Slagelse, Denmark

Location

MeSH Terms

Interventions

Middle Ear Ventilation

Intervention Hierarchy (Ancestors)

OstomySurgical Procedures, OperativeOtologic Surgical ProceduresOtorhinolaryngologic Surgical Procedures

Study Officials

  • Preben Homoee, MD

    Zealand University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
questionnaires and sleep outcome measures will be assessed by masked person
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: RCT with an intervention and a control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 17, 2017

First Posted

October 25, 2023

Study Start

January 20, 2017

Primary Completion

June 30, 2022

Study Completion

August 30, 2022

Last Updated

January 16, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

All results in database will be published anonymously after study termination

Locations